학술논문

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
Document Type
article
Author
Hisani N HorneCharles C ChungHan ZhangKai YuLudmila Prokunina-OlssonKyriaki MichailidouManjeet K BollaQin WangJoe DennisJohn L HopperMelissa C SoutheyMarjanka K SchmidtAnnegien BroeksKenneth MuirArtitaya LophatananonPeter A FaschingMatthias W BeckmannOlivia FletcherNichola JohnsonElinor J SawyerIan TomlinsonBarbara BurwinkelFrederik MarmePascal GuénelThérèse TruongStig E BojesenHenrik FlygerJavier BenitezAnna González-NeiraHoda Anton-CulverSusan L NeuhausenHermann BrennerVolker ArndtAlfons MeindlRita K SchmutzlerHiltrud BrauchUte HamannHeli NevanlinnaSofia KhanKeitaro MatsuoHiroji IwataThilo DörkNatalia V BogdanovaAnnika LindblomSara MargolinArto MannermaaVeli-Matti KosmaGeorgia Chenevix-TrenchkConFab/AOCS InvestigatorsAnna H WuDavid Ven den BergAnn SmeetsHui ZhaoJenny Chang-ClaudeAnja RudolphPaolo RadiceMonica BarileFergus J CouchCeline VachonGraham G GilesRoger L MilneChristopher A HaimanLoic Le MarchandMark S GoldbergSoo H TeoNur A M TaibVessela KristensenAnne-Lise Borresen-DaleWei ZhengMartha ShrubsoleRobert WinqvistArja Jukkola-VuorinenIrene L AndrulisJulia A KnightPeter DevileeCaroline SeynaeveMontserrat García-ClosasKamila CzeneHatef DarabiAntoinette HollestelleJohn W M MartensJingmei LiWei LuXiao-Ou ShuAngela CoxSimon S CrossWilliam BlotQiuyin CaiMitul ShahCraig LuccariniCaroline BaynesPatricia HarringtonDaehee KangJi-Yeob ChoiMikael HartmanKee Seng ChiaMaria KabischDiana TorresAnna JakubowskaJan LubinskiSuleeporn SangrajrangPaul BrennanSusan SlagerDrakoulis YannoukakosChen-Yang ShenMing-Feng HouAnthony SwerdlowNick OrrJacques SimardPer HallPaul D P PharoahDouglas F EastonStephen J ChanockAlison M DunningJonine D Figueroa
Source
PLoS ONE, Vol 11, Iss 8, p e0160316 (2016)
Subject
Medicine
Science
Language
English
ISSN
1932-6203
Abstract
The Cancer Genetic Markers of Susceptibility genome-wide association study (GWAS) originally identified a single nucleotide polymorphism (SNP) rs11249433 at 1p11.2 associated with breast cancer risk. To fine-map this locus, we genotyped 92 SNPs in a 900kb region (120,505,799-121,481,132) flanking rs11249433 in 45,276 breast cancer cases and 48,998 controls of European, Asian and African ancestry from 50 studies in the Breast Cancer Association Consortium. Genotyping was done using iCOGS, a custom-built array. Due to the complicated nature of the region on chr1p11.2: 120,300,000-120,505,798, that lies near the centromere and contains seven duplicated genomic segments, we restricted analyses to 429 SNPs excluding the duplicated regions (42 genotyped and 387 imputed). Per-allelic associations with breast cancer risk were estimated using logistic regression models adjusting for study and ancestry-specific principal components. The strongest association observed was with the original identified index SNP rs11249433 (minor allele frequency (MAF) 0.402; per-allele odds ratio (OR) = 1.10, 95% confidence interval (CI) 1.08-1.13, P = 1.49 x 10-21). The association for rs11249433 was limited to ER-positive breast cancers (test for heterogeneity P≤8.41 x 10-5). Additional analyses by other tumor characteristics showed stronger associations with moderately/well differentiated tumors and tumors of lobular histology. Although no significant eQTL associations were observed, in silico analyses showed that rs11249433 was located in a region that is likely a weak enhancer/promoter. Fine-mapping analysis of the 1p11.2 breast cancer susceptibility locus confirms this region to be limited to risk to cancers that are ER-positive.